Reading Time: 3 minutesResearchers from University College London led by Dr Pietro Fratta and Dr John Thornton found that muscle imaging can help distinguish Amyotrophic Lateral Sclerosis (ALS)
Search Results for: biomarkers
Reading Time: 4 minutesRecently published results from the open-label Lighthouse trial investigating safety of the drug Triumeq in people with MND revealed the treatment was safe and ready
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Models of MND Research we fund Treatments
How animals are helping to improve our understanding of MND
Reading Time: 6 minutes‘From antibiotics and insulin to blood transfusions and treatments for cancer or HIV, virtually every medical achievement in the past century has depended directly or
Reading Time: 4 minutesAfter its successful premiere in 2017, the University of Oxford organised another meeting of people affected by inherited MND, called ‘Families for the Treatment of
Reading Time: 10 minutes“The annals of ALS clinical trials is strewn with failed studies. Only two out of more than 70 clinical trials have been positive, and even
Reading Time: 7 minutesIn the last decade, the MND Association has invested millions in research within the UK and across the world. We are a leader in the
Reading Time: 3 minutesIt has been almost a year since we announced that AMBRoSIA (A Multicentre Biomarker Resource Strategy In ALS) had begun to recruit participants (read the
Reading Time: 8 minutesFollowing on from our previous catch-up blog on clinical management talks presented at the Symposium, here is a continuation that looks at talks focusing on
Reading Time: 3 minutesAt the end of a very busy Day 2 of the Symposium, I sat down with my colleagues for a quick chat. After a while,